Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617-Reference-Cited by-同舟云学术

Treatment of brain metastases of castration-resistant prostate cancer with 225Ac-PSMA-617

Published:2019-05-21 Issue:8 Volume:46 Page:1756-1757
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Sathekge Mike M.^ORCID,Bruchertseifer Frank,Lawal Ismaheel O.,Vorster Mariza,Knoesen Otto,Lengana Thabo,Boshomane Tebatso G.,Mokoala Kgomotso K.,Morgenstern Alfred

Publisher

Springer Science and Business Media LLC

Subject

Radiology Nuclear Medicine and imaging,General Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-019-04354-z.pdf

Reference5 articles.

1. Tremont-Lukats IW, Bobustuc G, Lagos GK, Lolas K, Kyritsis AP, Puduvalli VK. Brain metastasis from prostate carcinoma: The M.D. Anderson Cancer Center experience. Cancer. 2003;98(2):363–8.

2. Wei X, Schlenkhoff C, Schwarz B, Essler M, Ahmadzadehfar H. Combination of 177Lu-PSMA-617 and external radiotherapy for the treatment of cerebral metastases in patients with castration-resistant metastatic prostate cancer. Clin Nucl Med. 2017;42(9):704–6.

3. Kratochwil C, Bruchertseifer F, Rathke H, Hohenfellner M, Giesel FL, Haberkorn U, et al. Targeted α-therapy of metastatic castration-resistant prostate cancer with 225Ac-PSMA-617: swimmer-plot analysis suggests efficacy regarding duration of tumor control. J Nucl Med. 2018;59(5):795–802.

4. Sathekge M, Bruchertseifer F, Knoesen O, Reyneke F, Lawal I, Lengana T, et al. Morgenstern A. 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study. Eur J Nucl Med Mol Imaging. 2019;46(1):129–38.

5. Kratochwil C, Bruchertseifer F, Giesel FL, Weis M, Verburg FA, Mottaghy F, et al. 225Ac-PSMA-617 for PSMA-targeted α-radiation therapy of metastatic castration-resistant prostate cancer. J Nucl Med. 2016;57(12):1941–4.

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Leptomeningeal metastases in prostate cancer: A review of the current literature;Current Urology;2024-09

2. Advances in PSMA Alpha Theragnostics;Seminars in Nuclear Medicine;2024-07

3. Prostate-specific Membrane Antigen: Alpha-labeled Radiopharmaceuticals;PET Clinics;2024-07

4. Brain metastasis: An insight into novel molecular targets for theranostic approaches;Critical Reviews in Oncology/Hematology;2024-06

5. Potential of PSMA-targeting radioligand therapy for malignant primary and secondary brain tumours using super-selective intra-arterial administration: a single centre, open label, non-randomised prospective imaging study;eBioMedicine;2024-04